Minimally Invasive Robotics: Achieved revenue of 551 million yuan in 2025, with breakthrough progress in the commercialization of core products

Recently, MicroPort Robotics released its performance announcement for the year ended December 31, 2025. The company recorded revenue of 551 million yuan, up 114.2% year over year. Gross profit was 267 million yuan, up 209.2%. On a loss before tax basis, the company’s loss was 254 million yuan, which was 60.7% lower than last year. Loss for the year was also 254 million yuan, down 60.7% year over year. Adjusted net loss was 165 million yuan, down 65.8% year over year. Loss per share was 0.24 yuan, down 63.6% from 0.66 yuan last year.

The main reason for the company’s sharp growth in performance is that the commercialization of its core product, the G-MARX® laparoscopic surgical robot, has achieved breakthrough progress, particularly with significant sales growth in overseas markets. During the year, the company secured more than 100 new orders for overseas markets. Revenue from overseas markets was more than five times that of the previous year, demonstrating strong momentum for global expansion. Management noted that, thanks to the successful implementation of revenue growth, strategic focus, and cost reduction and efficiency improvement measures, free cash flow achieved a net inflow in the second half of 2025.

In terms of business segments, the company’s main sources of revenue are the sales of surgical robot systems, instruments and accessories, as well as the provision of services. Its sales contribution from overseas markets increased to 73%, becoming the core driver of revenue growth. Overall, the company’s global market layout and product commercialization progress have been significant, especially in the field of surgical robots, showing strong market competitiveness and the potential for continued development.

(MicroPort Robotics announcement)

(Editor: Yang Yan, Lin Chen)

Keywords:

                                                            Medical